IL1RL1 and lung adenocarcinoma: While ST2+ Tregs promote type 2 allergic airway inflammation, ST2+ Tregs suppress IFN-γ–mediated inflammation in adipose tissue, during influenza infections, and in lung adenocarcinoma (24–29).